Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

758 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation.
Kröger N, Panagiota V, Badbaran A, Zabelina T, Triviai I, Araujo Cruz MM, Shahswar R, Ayuk F, Gehlhaar M, Wolschke C, Bollin R, Walter C, Dugas M, Wiehlmann L, Lehmann U, Koenecke C, Chaturvedi A, Alchalby H, Stadler M, Eder M, Christopeit M, Göhring G, Koenigsmann M, Schlegelberger B, Kreipe HH, Ganser A, Stocking C, Fehse B, Thol F, Heuser M. Kröger N, et al. Among authors: eder m. Biol Blood Marrow Transplant. 2017 Jul;23(7):1095-1101. doi: 10.1016/j.bbmt.2017.03.034. Epub 2017 Apr 4. Biol Blood Marrow Transplant. 2017. PMID: 28389256 Free article.
Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies.
Kümpers P, Koenecke C, Hecker H, Hellpap J, Horn R, Verhagen W, Buchholz S, Hertenstein B, Krauter J, Eder M, David S, Göhring G, Haller H, Ganser A. Kümpers P, et al. Among authors: eder m. Blood. 2008 Sep 1;112(5):2139-48. doi: 10.1182/blood-2007-12-130021. Epub 2008 May 15. Blood. 2008. PMID: 18483397 Free article.
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.
Thol F, Gabdoulline R, Liebich A, Klement P, Schiller J, Kandziora C, Hambach L, Stadler M, Koenecke C, Flintrop M, Pankratz M, Wichmann M, Neziri B, Büttner K, Heida B, Klesse S, Chaturvedi A, Kloos A, Göhring G, Schlegelberger B, Gaidzik VI, Bullinger L, Fiedler W, Heim A, Hamwi I, Eder M, Krauter J, Schlenk RF, Paschka P, Döhner K, Döhner H, Ganser A, Heuser M. Thol F, et al. Among authors: eder m. Blood. 2018 Oct 18;132(16):1703-1713. doi: 10.1182/blood-2018-02-829911. Epub 2018 Sep 6. Blood. 2018. PMID: 30190321 Free PMC article.
Increased Late Noncardiac Nonrelapse Mortality in Patients with Atrial Fibrillation Diagnosed During Their Hospital Stay for Allogeneic Stem Cell Transplantation.
Lueck C, Panagiota V, Dammann E, Gabdoulline R, Berliner D, Veltmann C, Heuser M, Beutel G, Ganser A, Eder M. Lueck C, et al. Among authors: eder m. Transplant Cell Ther. 2022 Sep;28(9):609.e1-609.e8. doi: 10.1016/j.jtct.2022.06.010. Epub 2022 Jun 18. Transplant Cell Ther. 2022. PMID: 35724849 Free article.
Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation.
Panagiota V, Thol F, Markus B, Fehse B, Alchalby H, Badbaran A, Lehmann U, Koenecke C, Shahswar R, Chaturvedi A, Stadler M, Eder M, Göhring G, Koenigsmann M, Kloos A, Trummer A, Schroeder T, Kobbe G, Thiede C, Platzbecker U, Schlegelberger B, Kreipe HH, Ganser A, Kröger N, Heuser M. Panagiota V, et al. Among authors: eder m. Leukemia. 2014 Jul;28(7):1552-5. doi: 10.1038/leu.2014.66. Epub 2014 Feb 7. Leukemia. 2014. PMID: 24504025 No abstract available.
Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML.
Koenecke C, Kümpers P, Lukasz A, Dammann E, Verhagen W, Göhring G, Buchholz S, Krauter J, Eder M, Schlegelberger B, Ganser A. Koenecke C, et al. Among authors: eder m. Ann Hematol. 2010 May;89(5):459-67. doi: 10.1007/s00277-009-0869-5. Ann Hematol. 2010. PMID: 20054548 Free article.
Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome.
Buchholz S, Dammann E, Stadler M, Krauter J, Beutel G, Trummer A, Eder M, Ganser A. Buchholz S, et al. Among authors: eder m. Eur J Haematol. 2012 Jan;88(1):52-60. doi: 10.1111/j.1600-0609.2011.01703.x. Epub 2011 Nov 17. Eur J Haematol. 2012. PMID: 21883483 Clinical Trial.
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.
Borchers S, Bremm M, Lehrnbecher T, Dammann E, Pabst B, Wölk B, Esser R, Yildiz M, Eder M, Stadler M, Bader P, Martin H, Jarisch A, Schneider G, Klingebiel T, Ganser A, Weissinger EM, Koehl U. Borchers S, et al. Among authors: eder m. PLoS One. 2012;7(12):e50248. doi: 10.1371/journal.pone.0050248. Epub 2012 Dec 13. PLoS One. 2012. PMID: 23272059 Free PMC article.
Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation.
Dobbelstein C, Ahn KW, Haagenson M, Hale GA, van Rood JJ, Miklos D, Waller EK, Spellman SR, Fernandez-Vina M, Ganser A, Aljurf M, Bornhaeuser M, Gupta V, Marino SR, Pollack MS, Reddy V, Eder M, Lee SJ. Dobbelstein C, et al. Among authors: eder m. Biol Blood Marrow Transplant. 2013 May;19(5):741-5. doi: 10.1016/j.bbmt.2013.01.020. Epub 2013 Feb 1. Biol Blood Marrow Transplant. 2013. PMID: 23380341 Free PMC article.
758 results